通过系统的代谢工程来增强大肠杆菌中尼古丁胺胺单核酸的产生
Zhaoyuan Zhang1, Jiehu Liu1, Meng Wang1
1School of Biotechnology, State Key Laboratory of Food Science and Resources, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu 214122, China; Key Laboratory of Industrial Biotechnology Ministry of Education, and International Joint Laboratory on Food Safety, Jiangnan University, 1800 Lihu Road, Wuxi, Jiangsu 214122, China.
Journal of biotechnology
|March 29, 2025
概括
改造了大肠杆菌以产生尼古丁胺胺单核酸 (NMN),这是一个重要的NAD+前体. 实现了创纪录的4.96μg/L细胞外NMN产量,为商业NMN生产铺平了道路.
科学领域:
- 生物技术是生物技术.
- 代谢工程是代谢工程.
- 合成生物学 合成生物学
背景情况:
- 尼古丁胺胺单核酸 (NMN) 是一个关键的NAD+前体,工业需求日益增长.
- 目前的NMN生产方法需要优化效率和产量.
研究的目的:
- 设计一种大肠杆菌菌株,以提高NMN的细胞外生产.
- 优化新陈代谢途径以增加NMN生物合成和产量.
主要方法:
- 构建了一种具有减少NMN降解和增强NMN出口的大肠杆菌菌株.
- 破坏了pncA基因以尽量减少尼古丁胺胺 (NAM) 降解.
- 通过优化酸路径和减弱糖解,重塑葡萄糖代谢.
- 平衡的细胞内氧化还原稳定,改善NMN的产量.
主要成果:
- 使用葡萄糖和2g/L的NAM,实现了4.96μg/L的细胞外NMN产量记录.
- 证明了核酸化合物生产的成功代谢工程策略.
结论:
- 改造的大肠杆菌菌株显著提高了NMN的产量.
- 这项研究为NMN和其他核酸化合物的商业规模制造提供了基础.
相关概念视频
Biosynthesis in Bacteria
1.0K
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
1.0K
Evolution of New Traits in Microbes
199
Microorganisms evolve rapidly due to their large population sizes and short generation times, often exhibiting measurable changes within days under laboratory conditions. Natural selection acts on standing genetic variation, enabling the retention and amplification of beneficial traits that confer fitness advantages in changing environments.Adaptive Pigment Regulation in RhodobacterIn Rhodobacter, a genus of purple non-sulfur bacteria, light-harvesting pigments such as bacteriochlorophyll and...
199
Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Production of Antibiotics
265
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
265
Production of Pharmaceuticals
90
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
90


